NSAIDs for Pediatric ENT Infections Clinical Practice Guidelines (2019)

French Society of Otorhinolaryngology (SFORL)

This is a quick summary of the guidelines without analysis or commentary. For more information, go directly to the guidelines by clicking the link in the reference.

September 30, 2019

The French Society of Otorhinolaryngology (SFORL) issued clinical practice guidelines for the use of NSAIDs in pediatric ENT infections in September 2019.[1]

In uncomplicated pediatric ENT infections, such as acute otitis media, tonsillitis, upper respiratory tract infections, and maxillary sinusitis, nonsteroidal antiinflammatory drugs (NSAIDs) are indicated at analgesic doses (eg, ibuprofen 20-30 mg/kg/day) in combination with acetaminophen in the following circumstances:

  • The pain intensity is determined to be medium (ie, a visual analogue scale [VAS] score of 3-5 or "Evaluation Enfant Douleur" [EVENDOL] child pain score of 4-7) and insufficiently responsive to first-line acetaminophen (residual VAS ≥3 or EVENDOL ≥4)

  • Pain is moderate to intense (VAS score 5-7 or EVENDOL score 7-10)

When combined, acetaminophen and ibuprofen should be taken simultaneously every 6 hours.

NSAIDS should not be prescribed to pediatric patients with severe or complicated ENT infections.

NSAIDs should be suspended in patients with infections that have unusual clinical presentations in terms of duration or symptoms.

NSAIDs should not be given for more than 72 hours.

For more information, please go to Acute Otitis Media.

For more Clinical Practice Guidelines, please go to Guidelines.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: